Skip to main content
Log in

Stringent glycaemic control not cost effective in all patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. proportion of glycosylated haemoglobin

  2. 2017 US dollars

Reference

  • Shao H, et al. Influence of Diabetes Complications on HbA1c Treatment Goals Among Older U.S. Adults: A Cost-Effectiveness Analysis. Diabetes Care : 17 Sep 2019. Available from: URL: http://doi.org/10.2337/dc19-0381

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stringent glycaemic control not cost effective in all patients. PharmacoEcon Outcomes News 838, 27 (2019). https://doi.org/10.1007/s40274-019-6272-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6272-0

Navigation